openPR Logo
Press release

Depression Drugs Market is Growing at CAGR of 4% to Achieve US$ 20 Billion by 2031 | Fact.MR

05-13-2024 08:05 AM CET | Health & Medicine

Press release from: Fact.MR

Depression Drugs Market

Depression Drugs Market

The depression medications market, which was estimated to be worth over US$ 6.5 billion in 2017, is expected to see bearishness soon. A recent Fact.MR analysis estimated that revenues would drop at a CAGR of -2%. The study indicates that even if the incidence of depression prevalence has increased over the past ten years, there has been a decrease in the demand for depression medications due to people's choice for cognitive behavior therapy (CBT) and their understanding of its possible negative effects. According to the report, the US led the world in the overall amount of depression medications marketed in 2018.

The World Health Organization (WHO) estimates that over 300 million people worldwide suffer from depression, making it one of the most prevalent illnesses. The National Institute of Mental Health (NIMH) estimates that 10.3 million adults in the US had at least one major depressive episode that caused substantial impairment. Adults between the ages of 18 and 25 had the highest frequency of such depressive episodes (10.9%), followed by female adults (8.5%) and male adults (4.8%). As to the Fact.MR survey, while depression remains a significant health concern, patients and the medical community are advocating for a non-pharmaceutical approach to minimize adverse effects and dependence. In order to promote long-term management of depression and other mental health conditions, healthcare professionals and patients are putting a greater emphasis on mindfulness-based techniques and cognitive behavior therapy (CBT).

Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=3215

Popularity of Tech-based Mental Health Apps Also Contributing to Low Sales

According to the study, as end users have more coping mechanisms available to them, the market for depression medications is likewise seeing a downturn. The enormous success of mental health applications like SuperBetter, Moodnotes, Headspace, Calm, and Pacifica has offered patients greater autonomy over their depression management. In light of the increasing amount of studies indicating benefits for both meditation and cognitive behavior therapy, the number of apps on the market has increased recently. According to the report, these developments will have an ongoing impact on the market for depression medications.

Depression Drugs Market to Remain Concentrated in Developed Nations

Due to a concentration of major market competitors and increased research and development of these treatments, North America and Europe account for the two largest global markets for depression drugs. The Asia Pacific region's market for depression drugs is predicted to expand negatively due to a lack of widespread understanding of antidepressant medications (ADMs), despite the fact that mental illnesses including schizophrenia and bipolar I disorder are becoming more common in China and India. Furthermore, alternative depression treatments have longer-lasting effects and are just as effective as ADM, which could impede the market's future growth for depression medications, particularly in Asia Pacific and the Middle East and Africa.

๐†๐ž๐ญ ๐‚๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง ๐จ๐ง ๐ญ๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐Ÿ๐จ๐ซ ๐’๐ฉ๐ž๐œ๐ข๐Ÿ๐ข๐œ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐’๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ฌ: https://www.factmr.com/connectus/sample?flag=RC&rep_id=3215

Depression Drugs Market: Segment-wise Insights

The global market for depression pharmaceuticals has been divided into several segments based on the type of drug used, including SSRIs, atypical antipsychotics, SNRIs, CNS stimulants, and others. Atypical antipsychotics are anticipated to account for the greatest market share of all of these.
According to disease category, major depressive disorder is predicted to hold the largest market share for depression medications. Bipolar I disorder, schizophrenia, and SSRI-induced bipolar disorder are further sub-segments.
Although depression medications are offered by hospital, internet, and retail pharmacies, the retail sector held the biggest market share in 2017 and is predicted to maintain this position through 2026.

Global Depression Drugs Market: Competitive Landscape

Some key players operating in the manufacturing of depression drugs are Otsuka Pharmaceutical Co., Ltd., Johnson & Johnson, Sebela Pharmaceutical Inc., GlaxoSmithKline plc, AstraZeneca plc, Eli Lilly and Company, Allergan USA, Inc., Takeda Pharmaceutical Company Ltd, Novartis AG, Pfizer, Inc., Alkermes Plc, H. Lundbeck, Bristol Myers Squibb Co., and Teva Pharmaceutical Industries Ltd.

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

๐€๐›๐จ๐ฎ๐ญ ๐…๐š๐œ๐ญ.๐Œ๐‘

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Depression Drugs Market is Growing at CAGR of 4% to Achieve US$ 20 Billion by 2031 | Fact.MR here

News-ID: 3493709 • Views: โ€ฆ

More Releases from Fact.MR

Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CAGR at a 5.3%
Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CA โ€ฆ
The global Fine Blanking Tools Market is set for steady growth over the next decade, driven by rising demand for high-precision components, ongoing industrial automation, and surging requirements from automotive, electronics, and aerospace sectors. According to a recent forecast, the market is expected to grow from approximately USD 948.1 million in 2025 to USD 1,430.6 million by 2035, at a compound annual growth rate (CAGR) of about 4.2 % betweenโ€ฆ
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; Akorn Inc; Hikma; Hameln Pharmaceutical; Accord; Others.
10-08-2025 | Health & Medicine
Fact.MR
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; โ€ฆ
The global benzodiazepine drugs market is projected to expand in the coming decade, driven by growing incidence of anxiety, insomnia, alcohol-withdrawal disorders, and advances in pharmaceutical formulations. According to a recent Fact.MR report, the market was valued at approximately USD 2.35 billion in 2022, and is expected to grow at a compound annual growth rate (CAGR) of 2.8% to reach USD 3.1 billion by 2032. Market Drivers & Outlook The demand forโ€ฆ
Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Advances in 2D, Cart-Based Systems & AI-Enabled Portability
10-08-2025 | Health & Medicine
Fact.MR
Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Adva โ€ฆ
The global Ultrasound Systems Market is on a strong growth trajectory, projected to rise from USD 10.8 billion in 2025 to approximately USD 19.7 billion by 2035, expanding at a CAGR of 6.2% during the forecast period. This growth is fueled by the rising demand for non-invasive diagnostic imaging, the increasing prevalence of chronic diseases, expanding healthcare infrastructure, and continuous technological innovations such as AI integration and portable imaging systems. Keyโ€ฆ
Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethicon US LLC, Cardica Inc., Smith & Nephew Plc, CONMED Corporation., Purple Surgical Inc., Dextera Surgical Inc, and Others.
10-08-2025 | Health & Medicine
Fact.MR
Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethico โ€ฆ
The global Surgical Staplers Market is forecast to show strong growth over the next decade, nearly doubling in value as demand surges for efficient, reliable wound closure in advanced surgical procedures. According to the latest Fact.MR Surgical Staplers Market Size & Share Forecast Outlook 2025-2035 report, the market is expected to grow from USD 6.0 billion in 2025 to USD 12.5 billion by 2035, at a compound annual growth rateโ€ฆ

All 5 Releases


More Releases for Depression

Ace Therapeutics Accelerates Preclinical Depression Investigation by Providing D โ€ฆ
Ace Therapeutics released depression-related behavior tests to accelerate preclinical depression research. New York, USA - December 24, 2024 - Ace Therapeutics, a preclinical contract research provider dedicated to offering comprehensive one-stop services, released the expansion of its research capabilities in the area of depression through the introduction of comprehensive depression-related behavior tests [https://www.acetherapeutics.com/psychiatry/depression-behavior-tests.html] in its preclinical investigation processes. This integral development aims to enhance the understanding of depressive disorders and expediteโ€ฆ
Postpartum Depression Global Market Report 2024 - Postpartum Depression Market S โ€ฆ
The Business Research Company recently released a comprehensive report on the Global Postpartum Depression Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The postpartum depression marketโ€ฆ
Depression Apps Market - Tools for Resilience, Tools for Life: Depression Apps f โ€ฆ
Newark, New Castle, USA: The "Depression Apps Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Depression Apps Market: https://www.growthplusreports.com/report/depression-apps-market/8782 This latest report researches the industry structure, sales, revenue,โ€ฆ
Depression Apps Market - Navigating the Path to Mental Wellbeing: Harnessing the โ€ฆ
Newark, New Castle, USA - new report, titled Depression Apps Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Depression Apps market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Depression Apps market. The report offers an overview of the market, whichโ€ฆ
Depression Treatment Device Market: Information by Product Type (Light Therapies โ€ฆ
Depression is characterized by multiple mental health challenges that involve a lack of positivity, suicidal thoughts, insomnia, anxiety, loss of appetite, and sadness. Depression is caused by a combination of biological, genetic, environmental, and psychological factors. Globally, the prevalence of depression is increasing at an alarming rate. About 300 million people of all ages suffered from depression and the suicide rate rose to about 8,00,000 individuals in 2018. As perโ€ฆ
Depression Drugs Market: Increase in Cases of Depression to Boost Market Growth
Transparency Market Research (TMR) has published a new report titled, โ€œDepression Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018โ€“2026โ€. According to the report, the global depression drugs market was valued at US$ 6,500 Mn in 2017 and is anticipated to decline at a CAGR of 2% from 2018 to 2026. The report suggests that rise in incidence of major depression disorders is projected to driveโ€ฆ